1 / 23

Incorporating New Therapies in IBS-C

Incorporating New Therapies in IBS-C. Patient Case. Is it Irritable Bowel Syndrome With Constipation?. What is IBS?. Pathophysiology of IBS. When Constipation Does Not Respond to First-line Treatment. IBS Diagnostic Testing. Cornerstones of Treatment for the Patient With IBS.

duena
Télécharger la présentation

Incorporating New Therapies in IBS-C

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Incorporating New Therapies in IBS-C

  2. Patient Case

  3. Is it Irritable Bowel Syndrome With Constipation?

  4. What is IBS?

  5. Pathophysiology of IBS

  6. When Constipation Does Not Respond to First-line Treatment

  7. IBS Diagnostic Testing

  8. Cornerstones of Treatment for the Patient With IBS

  9. Are Behavioral Therapies Useful in IBS?

  10. Antispasmodics, Antidepressants, Laxatives

  11. New and Emerging Treatments

  12. Long-term Efficacy of Lubiprostone:Monthly Responder Rates

  13. Effects of Guanylate Cyclase-C Receptor Activation

  14. Linaclotide for IBS-C: Adequate Relief of IBS Symptoms for ≥ 13/26 Weeks

  15. Prucalopride for Chronic ConstipationPost-hoc Analysis of Phase III Data From Patients Who Had Failed Previous Laxative Therapies

  16. Elobixibat: Mechanism of Action

  17. Patient Case: Conclusion

  18. Abbreviations

  19. Abbreviations (cont)

  20. References

  21. References (cont)

  22. References (cont)

  23. References (cont)

More Related